04/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/9/2020. This 12-page guidance provides recommendations to healthcare providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency. The guidance also provides recommendations to blood establishments on the collection of COVID-19 convalescent plasma. (PDF)
04/09/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 4/9/2020. This seven-page document proposes an updated strategy for COVID-19 surveillance at national and European Union/European Economic Area (EU/EEA) levels that specifically aims to reconcile the data needs for effective pandemic response with what is still feasible in countries and within healthcare systems under siege, while taking into account guidance issued by the World Health Organization. (PDF)
04/09/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/9/2020. This web page provides answers to questions about providing hemodialysis to patients with suspected or confirmed COVID-19 in acute care settings, and links to related pages. (Text)
04/09/2020 12:00 AM EDT
Source: United Nations Population Fund (UNFPA). Published: 4/9/2020. This 22-page Guidance Note offers a list of recommendations for maternity services during the COVID-19 pandemic, based on a combination of World Health Organization guidelines, good practice, and expert advice based on the latest scientific research. The goals are to protect maternity care providers and the maternal health workforce, provide safe and effective maternity care to women, and maintain and protect maternal health systems. (PDF)
04/08/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QuantiVirus™ SARS-CoV-2 Test kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 8, 2020. The QuantiVirus™ SARS-CoV-2 Test kit is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
04/08/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BD SARS-CoV-2 Reagents for BD MAX™ System, which received an Emergency Use Authorization from the Food and Drug Administration on April 8, 2020. The BD SARS-CoV-2 Reagents for BD MAX™ System is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
04/08/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 4/8/2020. This 39-page report details how in a few European Union/European Economic Area (EU/EEA) countries, the number of new COVID-19 cases and new deaths reported daily appears to have decreased slightly. However, many EU/EEA countries are currently testing only severe or hospitalized cases; therefore, these trends should be interpreted with caution. Despite early evidence from Italy and Austria that the numbers of cases and deaths are declining, there is currently no indication at the EU/EEA level that the peak of the epidemic has been reached. (PDF)
Rapid Expert Consultation on SARS-CoV-2 Laboratory Testing for the COVID-19 Pandemic (April 8, 2020)
04/08/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/8/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This eight-page publication provides scientifically grounded principles that are relevant to decision-making about the interpretation of laboratory tests for COVID-19. (Text)
04/08/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/8/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This eight-page publication responds to questions concerning the effectiveness of homemade fabric masks worn by the general public to protect others, as distinct from protecting the wearer during the COVID-19 pandemic. (Text)
04/08/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/8/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This seven-page publication responds to questions concerning viral shedding and antibody response for the COVID-19 pandemic, and discusses optimum duration of isolation of cases. (Text)
04/08/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 4/8/2020. This six-page document provides the European Centre for Disease Prevention and Control (ECDC) opinion on the suitability of face masks and other face covers in the community by individuals who are not ill in order to reduce potential pre-symptomatic or asymptomatic transmission of COVID-19 from the mask wearer to others. (PDF)
04/08/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 4/8/2020. This memorandum expands temporary enforcement guidance provided in OSHA’s March 14, 2020, memorandum to Compliance Safety and Health Officers for enforcing annual fit-testing requirements of the Respiratory Protection standard, with regard to supply shortages of N95s or other filtering facepiece respirators (FFRs) due to the coronavirus disease 2019 (COVID-19) pandemic. This memorandum will take effect immediately and remain in effect until further notice. (Text)
04/08/2020 12:00 AM EDT
Source: National Academies of Sciences, Engineering, and Medicine, Transportation Research Board (TRB). Published: 4/8/2020. This one-hour, 34-minute webinar explores the impacts of COVID-19 on the supply chain and logistics industries. Presenters discuss lessons learned from past freight transportation and supply chain disruptions, identify research that has been done to address resilience in the supply chain, describe how to mitigate the economic impacts of these disruptions, and provide commentary on current supply chain disruptions due to COVID-19. (Video or Multimedia)
04/08/2020 12:00 AM EDT
Source: National Mass Care Council. Published: 4/8/2020. This seven-page document provides an overview of necessary changes to normal shelter operations in order to provide a safe and effective shelter where there is COVID-19. (PDF)
04/08/2020 12:00 AM EDT
Source: Cochrane Library. Published: 4/8/2020. This report summarizes a rapid review to assess the effects of quarantine (alone or in combination with other measures) of individuals who had contact with confirmed cases of COVID‐19, who traveled from countries with a declared outbreak, or who live in regions with high transmission of the disease. (Text)
04/07/2020 12:00 AM EDT
Source: Child Care Aware of America. Published: 4/7/2020. Presenters in this one-hour, five-minute webinar discuss several “pop up” child care solutions that have been created in response to the coronavirus pandemic. They discuss what still needs to be done, and how to leverage technology and data—to not only meet the demand caused by COVID-19, but also support families far into the future. (Video or Multimedia)
04/07/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/7/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This eight-page publication responds to questions concerning COVID-19 virus survival in relation to temperature and humidity, and potential for seasonal reduction and resurgence of cases. (Text)
04/07/2020 12:00 AM EDT
Source: United Nations Office for Disaster Risk Reduction (UNDRR). Published: 4/7/2020. This article explores the systemic nature of risk made visible by the COVID-19 global pandemic, what needs to change, and how we can make the paradigm shift from managing disasters to managing risks. It discusses how the COVID-19 global pandemic is a complex manifestation of systemic risk, and includes elements of surprise and non-linearity. (Text)
04/07/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 4/7/2020. This seven-page document aims to help European Union/European Economic Area (EU/EEA) public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing, and follow-up, in the context of the COVID-19 response. (PDF)
04/06/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/6/2020. This web page provides guidance to healthcare facilities on the management of visitors to reduce the risk of transmission of SARS-CoV-2, also known as COVID-19 virus, to visitors of patients with suspected or confirmed COVID-19. It also considers preventing introduction of SARS-CoV2 into healthcare facilities by visitors during periods of community transmission; the risk of introduction into facilities increases as community transmission becomes more widespread. (Text)
04/02/2020 12:00 AM EDT
Source: International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). Published: 4/2/2020. This 24-page document is a report of aggregate data about the COVID-19 pandemic, with data entered for 5,532 individuals from 215 sites across 25 countries. The analysis detailed in this report includes only individuals for whom data collection commenced on or before March 19, 2020. (PDF)
04/01/2020 12:00 AM EDT
Source: Mongan Institute [Massachusetts General Hospital]. Published: 4/1/2020. This 42-page document was developed to assist institutions as they are trying to get approval for use of the COVID-19 Symptom Tracker app. These documents are templates to help them work toward getting IRB approval. The app will offer an opportunity to rapidly introduce an easy-to-use data collection tool to track COVID-19 exposure, symptoms, and outcomes in real-time during the acute phase of this pandemic, which will be invaluable for studies. (PDF)
04/01/2020 12:00 AM EDT
Source: Center for Economic and Social Research [University of Southern California Dornsife] (CESR). Published: 4/1/2020. This 58-page panel survey asks respondents about the impact of the coronavirus (COVID-19) pandemic on their lives. This survey is currently in the field. It contains questions (among others) on Consumer Behavior, Diet Lifestyle, Education, Employment Labor Market, Family, Health, Health Insurance, Housing, Income, Social Networks, and Subjective Well-Being. (PDF)
04/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/2020. Go.Data is a field data collection platform focusing on case data (including lab, hospitalization, and other variables though case investigation form) and contact data (including contact follow-up). This briefing package provides an orientation to the purpose, benefits, and utilization of Go.Data, consisting of seven modules with a narrated walk-through of the key features of the Go.Data web-based platform and mobile application. (Video or Multimedia)
04/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/1/2020. This six-page document provides recommendations for water, sanitation, and hygiene measures in healthcare facilities that are important to provide adequate patient care and protect both patients and staff during the COVID-19 pandemic. It includes a table of disinfectant solutions and their uses. (PDF)
03/31/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/31/2020. This seven-page document aims to help European Union/European Economic Area (EU/EEA) public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-19 response. (PDF)
03/26/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 3/26/2020. Certain populations, such as those with disabilities, may be impacted more significantly by COVID-19. This impact can be mitigated if the simple actions and protective measures described in this 10-page document are taken by key stakeholders. (PDF)
03/25/2020 12:00 AM EDT
Source: Child Care Aware of America. Published: 3/25/2020. Speakers in this one-hour webinar discuss a new interactive map that estimates the child care needs of essential workers during the COVID-19 pandemic. They offer technical assistance and collateral content that will support local, state, and national entities responsible for child care planning; advocacy partners and policymakers; and child care operators. (Video or Multimedia)
03/16/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 3/16/2020. This eight-page document provides answers to questions about ethics in the context of the COVID-19 pandemic, when surveillance is needed to reduce some of the uncertainty that surrounds the virus and its consequences. Health authorities must ensure that the information is collected rigorously, that all relevant cases are reported, and that data are managed responsibly, always taking the benefit of the population into account. (PDF)
02/01/2020 12:00 AM EST
Source: International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). Published: 2/2020. This 22-page protocol is designed for any severe or potentially severe acute infection of public health interest, including COVID-19. It is a standardized protocol that enables data and biological samples to be collected rapidly in a globally-harmonized manner. It can be used for the rapid, coordinated clinical investigation of confirmed cases of COVID-19. (Text)
11/01/2019 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 11/2019. This 96-page report examines the extent of federal agencies’ progress implementing plans to increase public access to federally funded research results, and coordination on public access plan implementation. It makes 37 recommendations to 16 agencies to promote full and effective implementation of agency public access plans. (PDF)
.png)
No hay comentarios:
Publicar un comentario